Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics


Spectrum Pharmaceuticals, Inc. (SPPI): $0.82

0.01 (+1.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SPPI to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

SPPI Stock Price Chart Interactive Chart >

Price chart for SPPI

SPPI Price/Volume Stats

Current price $0.82 52-week high $1.57
Prev. close $0.81 52-week low $0.32
Day low $0.80 Volume 1,129,800
Day high $0.83 Avg. volume 1,840,850
50-day MA $0.49 Dividend yield N/A
200-day MA $0.72 Market Cap 154.26M

Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio


Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.


SPPI Latest News Stream


Event/Time News Detail
Loading, please wait...

SPPI Latest Social Stream


Loading social stream, please wait...

View Full SPPI Social Stream

Latest SPPI News From Around the Web

Below are the latest news stories about SPECTRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SPPI as an investment opportunity.

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Spectrum common stock between December 6, 2021 through September 22, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by vi

Business Wire | February 3, 2023

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Business Wire | February 3, 2023

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Business Wire | February 2, 2023

Current Hot Stock Alert: Ideanomics, Inc. (NASDAQ:IDEX 0.00%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI 4.74%)

IDEX has seen its SMA50 which is now 4.91%. In looking the SMA 200 we see that the stock has seen a -55.22%. SPPI has seen its SMA50 which is … The post Current Hot Stock Alert: Ideanomics, Inc. (NASDAQ:IDEX 0.00%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI 4.74%) appeared first on Stocks Equity .

Stock Equity | February 1, 2023

SPPI stock rises as early Q4 2022 sales exceed consensus (NASDAQ:SPPI)

Micro-cap biotech Spectrum Pharmaceuticals (SPPI) jumped ~13% pre-market Tuesday after the company announced better than expected early sales for Q4 2022. Read the full story here.

Seeking Alpha | January 31, 2023

Read More 'SPPI' Stories Here

SPPI Price Returns

1-mo 70.02%
3-mo 101.28%
6-mo -32.23%
1-year 22.26%
3-year -70.18%
5-year -95.85%
YTD 122.52%
2022 -70.98%
2021 -62.76%
2020 -6.32%
2019 -58.40%
2018 -53.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7183 seconds.